Related Experiment Videos
A drug identification chart for the asthma clinic
British Journal of Diseases of the Chest
|April 1, 1985
Summary
Physicians may struggle to track complete patient therapy for conditions like asthma due to divided care. A new drug identification chart was developed and tested in a hospital asthma clinic to improve medication oversight.
Area of Science:
- Pediatrics
- Clinical Pharmacy
- Respiratory Medicine
Background:
- Asthma management often involves multiple healthcare providers, including general practitioners (GPs) and hospital specialists.
- Fragmented care can lead to challenges in physicians fully understanding a patient's complete medication regimen.
- Incomplete knowledge of a patient's therapy can potentially impact treatment decisions and patient outcomes.
Purpose of the Study:
- To design a drug identification chart to aid physicians in recognizing the complete therapy prescribed to asthma patients.
- To evaluate the utility and effectiveness of this chart in a clinical setting.
Main Methods:
- A novel drug identification chart was developed.
- The chart's implementation and use were examined within the asthma clinic at Bristol Children's Hospital.
Main Results:
- The study assessed the practical application of the drug identification chart in managing asthma patients.
- Data on the chart's impact on physician's appreciation of complete therapy was collected and analyzed.
Conclusions:
- The drug identification chart offers a potential solution to improve medication transparency in asthma care.
- Further evaluation is warranted to confirm the chart's benefits in enhancing comprehensive patient therapy management.